To Evaluate the Safety and Efficacy of RNK08954 in Patients With Advanced Gynecological Tumors.

by | Sep 30, 2026 | Clinical Trials | 0 comments

​ Conditions: Advanced Gynecologic Malignancies

Interventions: Drug: RNK08954

Sponsors: Ranok Therapuetics Co. Ltd.

Not yet recruiting Conditions: Advanced Gynecologic Malignancies
Interventions: Drug: RNK08954
Sponsors: Ranok Therapuetics Co. Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *